The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSage Group Regulatory News (SGE)

Share Price Information for Sage Group (SGE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,030.00
Bid: 1,029.50
Ask: 1,030.50
Change: 5.00 (0.49%)
Spread: 1.00 (0.097%)
Open: 1,030.00
High: 1,033.00
Low: 1,027.50
Prev. Close: 1,025.00
SGE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

25 Jul 2019 07:00

RNS Number : 6369G
Sage Group PLC
25 July 2019
 

Trading update for the nine months ended 30 June 2019

The Sage Group plc (the Group) is today issuing its trading update for the nine months ended 30 June 2019.

 

Financial performance

Group organic1 total revenue increased by 5.3% to £476m in the third quarter and 5.9% to £1,417m in the first nine months of the year.

Recurring revenue increased by 11.4% to £405m in the third quarter and 10.6% to £1,183m for the first nine months of the year. This was underpinned by software subscription growth of 28.3% to £752m, reflecting the continued focus on attracting new customers and migrating existing customers to subscription and the cloud.

The continuing strong recurring revenue growth in the first nine months of the year has, in part, been assisted by tailwinds from the weaker comparator in the prior year and particular strength in the UKI as new regulations on digital tax submissions attract new and existing customers to the latest version of software.

Software and software related services (SSRS) revenue declined by 15.5% to £195m for the first nine months of the year, reflecting the focus on driving high-quality subscription revenue, as well as some underperformance in X3 licences and services. The combined decline in SSRS and processing revenue in the first nine months was 13.0%.

Regionally, in the first nine months of the year, North America delivered revenue growth of 10.0% to £471m, with 12.3% recurring revenue driven by cloud connected solutions and Sage Intacct. The UKI continued its strong recovery with revenue growth of 7.2% to £300m and 15.6% recurring revenue growth driven by continuing success in Sage 50 cloud connected migrations. France delivered revenue growth of 2.0% to £206m and recurring revenue growth of 5.4%, driven by cloud connected solutions. Recurring revenue performance in other regions was largely in line with performance at H119.

In the portfolio view of revenue, recurring revenue growth of 10.6% reflects growth in the Future Sage Business Cloud Opportunity of 12.7% to £1,011m and flat performance of £172m in the Other portfolio.

Jonathan Howell, Chief Financial Officer, commented:

"We remain encouraged by the progress made in recurring revenue in the first nine months of FY19, reflecting Sage's focus on high-quality subscription and recurring revenue as we continue the transition to becoming a great SaaS company.

We expect full year FY19 recurring revenue growth to slightly exceed guidance of 8-9% and the combined decline in SSRS and processing revenue to be slightly greater than the decline seen in the first nine months of the year. We expect organic operating profit margin to be at the lower end of the guided range of 23-25%." 

Foreign exchange

Sterling has weakened against the US Dollar, leading to exchange rate tailwinds in the year to date.

Newcastle office move

As announced on 1 July 2019, Sage's flagship UK office is moving from North Park to Cobalt Business Park, both of which are located close to Newcastle, UK. The move will provide leading-edge working facilities to improve colleague experience. There will be a non-cash non-recurring charge in the region of £60m relating to the accelerated depreciation of the North Park building, with approximately 20% of this charge to be recognised in FY19 and the remainder in FY20.

1. All numbers throughout this document are organic unless otherwise stated. Full definitions are available in the appendix to the H119 results announcement.

 

Analyst and investor conference call

Jonathan Howell, CFO will be hosting a conference call at 08:30am today which will be webcast from a link on our investor relations website, www.sage.com/investors. The call may also be accessed using the dial-in number 0800 376 7922 (United Kingdom) or +44 (0) 2071 928 000 (International) and pin code 7970139. A replay of the call will also be available for one week after the event: dial-in number 0871 700 0471 (United Kingdom) or +44 (0) 3333 009 785 (International), pin code 7970139.

 

Enquiries

The Sage Group plc

+44(0) 191 294 3457

Jonathan Howell, Chief Financial Officer

Lauren Wholley, Investor Relations

Amy Lawson, Media

 

FTI Consulting +44(0) 20 3727 1000

Charles Palmer

Dwight Burden

 

About Sage

Sage is the global market leader for technology that helps businesses of all sizes manage everything from money to people - whether they're a start-up, scale-up or enterprise. We do this through Sage Business Cloud - the one and only business management solution that customers will ever need, comprising Accounting, Financials, Sage Intacct, Enterprise Management, People & Payroll and Payments & Banking.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTPGUAUMUPBGMC
Date   Source Headline
6th Mar 20234:42 pmRNSHolding(s) in Company
28th Feb 20231:50 pmRNSTotal Voting Rights
17th Feb 20235:22 pmRNSDirector/PDMR Shareholding
17th Feb 20235:02 pmRNSDirector/PDMR Shareholding
14th Feb 20233:59 pmRNSDirector/PDMR Shareholding
13th Feb 20236:16 pmRNSPublication of Final Terms
9th Feb 20239:32 amRNSDirector/PDMR Shareholding
7th Feb 20239:46 amRNSDirector/PDMR Shareholding
3rd Feb 202312:14 pmRNSDirector Declaration
2nd Feb 20233:31 pmRNSResult of AGM
2nd Feb 20239:57 amRNSDirector Declaration
31st Jan 20233:35 pmRNSSage: Publication of Base Prospectus
31st Jan 20233:00 pmRNSTotal Voting Rights
23rd Jan 20234:58 pmRNSDirector/PDMR Shareholding
19th Jan 20237:00 amRNSTrading Update for the 3 months ended 31 Dec 2022
30th Dec 202211:15 amRNSTotal Voting Rights
15th Dec 202211:21 amRNSDirector/PDMR Shareholding
8th Dec 20225:40 pmRNSDirector/PDMR Shareholding
8th Dec 20227:00 amRNSUpdate on financial reporting
7th Dec 20226:00 pmRNSDirector/PDMR Shareholding
7th Dec 202210:12 amRNSNotice of AGM
6th Dec 20226:13 pmRNSDirector/PDMR Shareholding
6th Dec 20225:23 pmRNSDirector/PDMR Shareholding
6th Dec 202210:25 amRNSBlock listing Interim Review
1st Dec 202211:03 amRNSAnnual Financial Report
30th Nov 20222:00 pmRNSTotal Voting Rights
24th Nov 202210:00 amRNSNon-executive Director Appointment
18th Nov 20229:13 amRNSDirector/PDMR Shareholding
16th Nov 20227:00 amRNSResults for the year ended 30 September 2022
15th Nov 20227:00 amRNSNon-executive Director Appointment
31st Oct 20223:00 pmRNSTotal Voting Rights
30th Sep 202211:45 amRNSTotal Voting Rights
20th Sep 20227:00 amRNSInvestor and Analyst Event
31st Aug 20223:44 pmRNSTotal Voting Rights
30th Aug 20225:10 pmRNSSage completes Lockstep acquisition
24th Aug 20223:37 pmRNSDirector/PDMR Shareholding
18th Aug 202210:19 amRNSDirector/PDMR Shareholding
16th Aug 20227:00 amRNSSage to acquire Lockstep
2nd Aug 20227:00 amRNSTrading update for nine months ended 30 June 2022
29th Jul 20224:04 pmRNSTotal Voting Rights
22nd Jul 20229:02 amRNSDirectorate Change
30th Jun 20224:10 pmRNSTotal Voting Rights
24th Jun 20224:34 pmRNSDirector/PDMR Shareholding
16th Jun 20223:38 pmRNSDirector/PDMR Shareholding
8th Jun 20224:48 pmRNSDirector/PDMR Shareholding
8th Jun 20229:00 amRNSDirector Declaration
7th Jun 20222:53 pmRNSDirector/PDMR Shareholding
6th Jun 20222:00 pmRNSBlock listing Interim Review
31st May 20225:09 pmRNSTotal Voting Rights
25th May 20225:24 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.